International Aids Vaccine Initiative

This study tests a new vaccine designed to protect against Marburg virus disease, a rare but severe illness. Researchers will give the vaccine to 112 healthy adults aged 18-50 to check if it is safe and triggers an immune response. The vaccine uses a modified virus to deliver a M…

This early-stage trial is testing a new HIV vaccine called GRAdHIVNE1 in 120 healthy adults, both with and without HIV, in Southern Africa. The vaccine uses a harmless gorilla virus to deliver HIV protein fragments, aiming to train the immune system to fight the virus. The main g…

This study tests a new vaccine called MTBVAC to see if it can prevent tuberculosis (TB) disease in people aged 14 to 45 who live in areas where TB is common. About 5,500 volunteers will receive either the vaccine or a placebo, and researchers will monitor them for up to 3 years t…